Lidanserin

Lidanserin
Systematic (IUPAC) name
4-(3-{3-[4-(4-fluorobenzoyl)-1-piperidinyl]propoxy}-4-methoxyphenyl)-2-pyrrolidinone
Identifiers
CAS Number 73725-85-6
ATC code None
PubChem CID 68919
ChemSpider 62146
Chemical data
Formula C26H31FN2O4
Molar mass 454.534 g/mol

Lidanserin (INN; ZK-33,839) is a drug which acts as a combined 5-HT2A and α1-adrenergic receptor antagonist.[1][2] It was developed as an antihypertensive agent but was never marketed.[1][2]

See also

References

  1. 1 2 Richard C. Allen (1989). Annual Reports in Medicinal Chemistry. Academic Press. p. 56. ISBN 978-0-12-040524-4. Retrieved 6 May 2012.
  2. 1 2 American Chemical Society; American Chemical Society. Chemical Abstracts Service (27 February 1989). Chemical abstracts. American Chemical Society. p. 114. Retrieved 6 May 2012.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.